Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

NCT03523572 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Urothelial Carcinoma

Interventions

DRUG: Trastuzumab deruxtecan
DRUG: Nivolumab

Sponsor

Daiichi Sankyo

Collaborators

[object Object]
[object Object]